After four biotech owners and a major trial failure, Beren's rare pediatric disease drug finally wins approval
A molecule designed by government scientists more than a decade ago has won FDA approval to treat infantile-onset Niemann-Pick disease type C, capping a winding …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Source link







